QSAM Biosciences, Inc. is a clinical stage company developing next-generation nuclear medicines for the treatment of cancer. Our lead product, Samarium-153 DOTMP (CycloSam®), is an advanced therapeutic radiopharmaceutical for multiple indications: treatment of primary bone cancer and metastatic bone cancers from the breast, prostate and lungs; bone marrow ablation; and reduction in external radiation. QSAM is not currently recruiting. To those receiving recruitment offers, this is unfortunately a scam and we advise you to cease any communications with any parties fraudulently representing QSAM.
View Top Employees from QSAM Biosciences, Inc.| Website | http://www.qsambio.com |
| Ticker | QSAM |
| Employees | 4 (4 on RocketReach) |
| Founded | 2020 |
| Address | 9442 N Capital of Texas Hwy, Austin, Texas 78759, US |
| Phone | (512) 343-4558 |
| Industry | Biotechnology Research, Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
| Competitors | Chiasma, Soleno Therapeutics, Inc., Spruce Biosciences, Tempest Therapeutics |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular QSAM Biosciences, Inc. employee's phone or email?
QSAM Biosciences, Inc. Questions
Adam King is the CFO of QSAM Biosciences, Inc..
4 people are employed at QSAM Biosciences, Inc..
QSAM Biosciences, Inc. is based in Austin, Texas.
The NAICS codes for QSAM Biosciences, Inc. are [541, 54].
The SIC codes for QSAM Biosciences, Inc. are [87, 873].
Top QSAM Biosciences, Inc. Employees
-
55+
-
42
-
41
-
55+
Related Companies
